Sense Raises $50m Series B to Accelerate Launch of COVID-19 molecular test on its Veros™ Instrument-Free Product Platform

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3xaRenC
via IFTTT